부광약품
ABOUT BUKWANG
Company Introduction
Vision & Mission
History
Manufacturing Facilities
Subsidiaries & Affiliates
Contact us
R&D
R&D Facilities
Pipeline
Latuda
JM-010
CP-012
Open Innovation
NEWS
IR
Financial Information
IR Reports
ANNUAL REPORT
PRODUCTS
Product Search
ETC
OTC
Health Functional Food
Personal Care Products
HOME
CONTACT US
KR
KR
EN
ABOUT BUKWANG
Company Introduction
Vision & Mission
History
Manufacturing Facilities
Subsidiaries & Affiliates
Contact us
R&D
R&D Facilities
Pipeline
Latuda
JM-010
CP-012
Open Innovation
JaguAhr
Protekt
NEWS
News
IR
Financial Information
IR Reports
ANNUAL REPORT
PRODUCTS
Product Search
ETC
OTC
Health Functional Food
Personal Care Products
NEWS
HOME
NEWS
NEWS
NEWS
ALL
Company news
Product news
R&D news
Company news | Bukwang Pharm. carries out reorganization into divisional sy..
Bukwang Pharm. announced its plan to reorganize the hospital sales department in..
2015.02.10
Company news | Bukwang Pharmaceuticals Co., Ltd. acquires CNS-specialized ..
-Contera Pharma to be Bukwang’s foothold for developing new drugs in Europe-Bukw..
2014.11.25
Company news | Bukwang Pharm. signs on term sheet for acquisition of Conter..
- Plans to develop JM-010 (candidate for LID), originally developed by Contera, ..
2014.09.23
16
17